Hoste og slimproduksjon kan være det første tegn på sykdom i luftveiene eller lungene, men hoste er en normal forsvarsmekanisme. Slimløsende og hostedempende medisiner gir ingen, eventuelt liten, behandlingsmessig fordel. De kan gi bivirkninger, dels alvorlige, og øke risiko for overdose hvis de kombineres med andre medisiner.
Referanser
- Isbister GK, Prior F, Kilham HA. Restricting cough and cold medications in children. J Paediatr Child Health 2012; 48(2):91–8.
- Schaeffer MK, Shehab N, Cohen AL, et al. Adverse events from cough and cold medication in children. Pediatrics 2008; 121(4):783–87.
- Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar – pediatric cough and cold medications. N Eng J Med 2007; 357(23):2321–4.
- Carr BC. Efficacy, abuse, and toxicity of over-the-counter cough and cold medications in the pediatric population. Currt Opin Pediatrics. 2006; 18(2):184–88.
- Irwin RS, Baumann MH, Bolser DC, et al; American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1_suppl): 1S–23S.
- https://www.uptodate.com/contents/the-common-cold-in-children-management-and-prevention